nodes	percent_of_prediction	percent_of_DWPC	metapath
Misoprostol—PTGER4—hematologic cancer	0.63	1	CbGaD
Misoprostol—PTGER4—hematopoietic system—hematologic cancer	0.00592	0.136	CbGeAlD
Misoprostol—PTGER2—blood—hematologic cancer	0.00399	0.0917	CbGeAlD
Misoprostol—PTGER4—blood—hematologic cancer	0.00392	0.09	CbGeAlD
Misoprostol—PTGER2—bone marrow—hematologic cancer	0.00387	0.0887	CbGeAlD
Misoprostol—PTGER2—lung—hematologic cancer	0.0035	0.0804	CbGeAlD
Misoprostol—PTGER4—lung—hematologic cancer	0.00344	0.0789	CbGeAlD
Misoprostol—PTGER2—testis—hematologic cancer	0.0033	0.0758	CbGeAlD
Misoprostol—PTGER4—testis—hematologic cancer	0.00324	0.0744	CbGeAlD
Misoprostol—PTGER3—lung—hematologic cancer	0.00291	0.0668	CbGeAlD
Misoprostol—PTGER3—testis—hematologic cancer	0.00275	0.063	CbGeAlD
Misoprostol—PTGER2—lymph node—hematologic cancer	0.0024	0.055	CbGeAlD
Misoprostol—PTGER4—lymph node—hematologic cancer	0.00235	0.0539	CbGeAlD
Misoprostol—PTGER3—lymph node—hematologic cancer	0.00199	0.0457	CbGeAlD
Misoprostol—Dinoprostone—PTGER4—hematologic cancer	0.00136	0.738	CrCbGaD
Misoprostol—Dinoprostone—SLC22A1—hematologic cancer	0.000482	0.262	CrCbGaD
Misoprostol—Hyperhidrosis—Betamethasone—hematologic cancer	3.61e-05	0.000174	CcSEcCtD
Misoprostol—Dizziness—Irinotecan—hematologic cancer	3.6e-05	0.000174	CcSEcCtD
Misoprostol—Abdominal pain—Etoposide—hematologic cancer	3.58e-05	0.000173	CcSEcCtD
Misoprostol—Body temperature increased—Etoposide—hematologic cancer	3.58e-05	0.000173	CcSEcCtD
Misoprostol—Urinary tract infection—Doxorubicin—hematologic cancer	3.58e-05	0.000173	CcSEcCtD
Misoprostol—Conjunctivitis—Doxorubicin—hematologic cancer	3.58e-05	0.000173	CcSEcCtD
Misoprostol—Syncope—Prednisone—hematologic cancer	3.57e-05	0.000173	CcSEcCtD
Misoprostol—Tinnitus—Methotrexate—hematologic cancer	3.56e-05	0.000172	CcSEcCtD
Misoprostol—Vomiting—Vincristine—hematologic cancer	3.56e-05	0.000172	CcSEcCtD
Misoprostol—Asthenia—Cisplatin—hematologic cancer	3.55e-05	0.000172	CcSEcCtD
Misoprostol—Fatigue—Triamcinolone—hematologic cancer	3.55e-05	0.000171	CcSEcCtD
Misoprostol—Rash—Vincristine—hematologic cancer	3.53e-05	0.000171	CcSEcCtD
Misoprostol—Dermatitis—Vincristine—hematologic cancer	3.53e-05	0.00017	CcSEcCtD
Misoprostol—Pain—Triamcinolone—hematologic cancer	3.52e-05	0.00017	CcSEcCtD
Misoprostol—Haematuria—Doxorubicin—hematologic cancer	3.52e-05	0.00017	CcSEcCtD
Misoprostol—Headache—Vincristine—hematologic cancer	3.51e-05	0.00017	CcSEcCtD
Misoprostol—Loss of consciousness—Prednisone—hematologic cancer	3.5e-05	0.000169	CcSEcCtD
Misoprostol—Hypotension—Betamethasone—hematologic cancer	3.49e-05	0.000169	CcSEcCtD
Misoprostol—Hypotension—Dexamethasone—hematologic cancer	3.49e-05	0.000169	CcSEcCtD
Misoprostol—Nausea—Carmustine—hematologic cancer	3.48e-05	0.000168	CcSEcCtD
Misoprostol—Epistaxis—Doxorubicin—hematologic cancer	3.48e-05	0.000168	CcSEcCtD
Misoprostol—Vomiting—Irinotecan—hematologic cancer	3.47e-05	0.000168	CcSEcCtD
Misoprostol—Vomiting—Mitoxantrone—hematologic cancer	3.47e-05	0.000168	CcSEcCtD
Misoprostol—Immune system disorder—Methotrexate—hematologic cancer	3.45e-05	0.000167	CcSEcCtD
Misoprostol—Nausea—Alitretinoin—hematologic cancer	3.45e-05	0.000167	CcSEcCtD
Misoprostol—Visual impairment—Epirubicin—hematologic cancer	3.45e-05	0.000167	CcSEcCtD
Misoprostol—Hypertension—Prednisone—hematologic cancer	3.44e-05	0.000166	CcSEcCtD
Misoprostol—Rash—Mitoxantrone—hematologic cancer	3.44e-05	0.000166	CcSEcCtD
Misoprostol—Rash—Irinotecan—hematologic cancer	3.44e-05	0.000166	CcSEcCtD
Misoprostol—Dermatitis—Irinotecan—hematologic cancer	3.43e-05	0.000166	CcSEcCtD
Misoprostol—Dermatitis—Mitoxantrone—hematologic cancer	3.43e-05	0.000166	CcSEcCtD
Misoprostol—Chills—Methotrexate—hematologic cancer	3.43e-05	0.000166	CcSEcCtD
Misoprostol—Headache—Mitoxantrone—hematologic cancer	3.41e-05	0.000165	CcSEcCtD
Misoprostol—Headache—Irinotecan—hematologic cancer	3.41e-05	0.000165	CcSEcCtD
Misoprostol—Nausea—Ifosfamide—hematologic cancer	3.41e-05	0.000165	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	3.4e-05	0.000164	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Betamethasone—hematologic cancer	3.4e-05	0.000164	CcSEcCtD
Misoprostol—Arthralgia—Prednisone—hematologic cancer	3.39e-05	0.000164	CcSEcCtD
Misoprostol—Myalgia—Prednisone—hematologic cancer	3.39e-05	0.000164	CcSEcCtD
Misoprostol—Feeling abnormal—Triamcinolone—hematologic cancer	3.39e-05	0.000164	CcSEcCtD
Misoprostol—Diarrhoea—Cisplatin—hematologic cancer	3.39e-05	0.000164	CcSEcCtD
Misoprostol—Anxiety—Prednisone—hematologic cancer	3.38e-05	0.000163	CcSEcCtD
Misoprostol—Alopecia—Methotrexate—hematologic cancer	3.38e-05	0.000163	CcSEcCtD
Misoprostol—Vomiting—Gemcitabine—hematologic cancer	3.38e-05	0.000163	CcSEcCtD
Misoprostol—Rash—Gemcitabine—hematologic cancer	3.35e-05	0.000162	CcSEcCtD
Misoprostol—Dermatitis—Gemcitabine—hematologic cancer	3.34e-05	0.000162	CcSEcCtD
Misoprostol—Hypersensitivity—Etoposide—hematologic cancer	3.34e-05	0.000161	CcSEcCtD
Misoprostol—Tinnitus—Epirubicin—hematologic cancer	3.34e-05	0.000161	CcSEcCtD
Misoprostol—Headache—Gemcitabine—hematologic cancer	3.33e-05	0.000161	CcSEcCtD
Misoprostol—Nausea—Vincristine—hematologic cancer	3.32e-05	0.000161	CcSEcCtD
Misoprostol—Hypersensitivity—Prednisolone—hematologic cancer	3.29e-05	0.000159	CcSEcCtD
Misoprostol—Dyspepsia—Dexamethasone—hematologic cancer	3.28e-05	0.000159	CcSEcCtD
Misoprostol—Dyspepsia—Betamethasone—hematologic cancer	3.28e-05	0.000159	CcSEcCtD
Misoprostol—Asthenia—Etoposide—hematologic cancer	3.25e-05	0.000157	CcSEcCtD
Misoprostol—Body temperature increased—Triamcinolone—hematologic cancer	3.25e-05	0.000157	CcSEcCtD
Misoprostol—Anaphylactic shock—Prednisone—hematologic cancer	3.25e-05	0.000157	CcSEcCtD
Misoprostol—Oedema—Prednisone—hematologic cancer	3.25e-05	0.000157	CcSEcCtD
Misoprostol—Nausea—Irinotecan—hematologic cancer	3.24e-05	0.000157	CcSEcCtD
Misoprostol—Nausea—Mitoxantrone—hematologic cancer	3.24e-05	0.000157	CcSEcCtD
Misoprostol—Immune system disorder—Epirubicin—hematologic cancer	3.23e-05	0.000156	CcSEcCtD
Misoprostol—Infection—Prednisone—hematologic cancer	3.23e-05	0.000156	CcSEcCtD
Misoprostol—Back pain—Methotrexate—hematologic cancer	3.22e-05	0.000156	CcSEcCtD
Misoprostol—Fatigue—Betamethasone—hematologic cancer	3.22e-05	0.000156	CcSEcCtD
Misoprostol—Fatigue—Dexamethasone—hematologic cancer	3.22e-05	0.000156	CcSEcCtD
Misoprostol—Chills—Epirubicin—hematologic cancer	3.21e-05	0.000155	CcSEcCtD
Misoprostol—Shock—Prednisone—hematologic cancer	3.2e-05	0.000155	CcSEcCtD
Misoprostol—Arrhythmia—Epirubicin—hematologic cancer	3.2e-05	0.000154	CcSEcCtD
Misoprostol—Pain—Dexamethasone—hematologic cancer	3.19e-05	0.000154	CcSEcCtD
Misoprostol—Pain—Betamethasone—hematologic cancer	3.19e-05	0.000154	CcSEcCtD
Misoprostol—Visual impairment—Doxorubicin—hematologic cancer	3.19e-05	0.000154	CcSEcCtD
Misoprostol—Alopecia—Epirubicin—hematologic cancer	3.16e-05	0.000153	CcSEcCtD
Misoprostol—Nausea—Gemcitabine—hematologic cancer	3.15e-05	0.000152	CcSEcCtD
Misoprostol—Vomiting—Cisplatin—hematologic cancer	3.15e-05	0.000152	CcSEcCtD
Misoprostol—Hyperhidrosis—Prednisone—hematologic cancer	3.14e-05	0.000152	CcSEcCtD
Misoprostol—Rash—Cisplatin—hematologic cancer	3.12e-05	0.000151	CcSEcCtD
Misoprostol—Dermatitis—Cisplatin—hematologic cancer	3.12e-05	0.000151	CcSEcCtD
Misoprostol—Diarrhoea—Etoposide—hematologic cancer	3.1e-05	0.00015	CcSEcCtD
Misoprostol—Tinnitus—Doxorubicin—hematologic cancer	3.09e-05	0.000149	CcSEcCtD
Misoprostol—Anaemia—Methotrexate—hematologic cancer	3.08e-05	0.000149	CcSEcCtD
Misoprostol—Feeling abnormal—Dexamethasone—hematologic cancer	3.07e-05	0.000149	CcSEcCtD
Misoprostol—Feeling abnormal—Betamethasone—hematologic cancer	3.07e-05	0.000149	CcSEcCtD
Misoprostol—Flatulence—Epirubicin—hematologic cancer	3.07e-05	0.000148	CcSEcCtD
Misoprostol—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.05e-05	0.000148	CcSEcCtD
Misoprostol—Gastrointestinal pain—Betamethasone—hematologic cancer	3.05e-05	0.000148	CcSEcCtD
Misoprostol—Hypersensitivity—Triamcinolone—hematologic cancer	3.03e-05	0.000146	CcSEcCtD
Misoprostol—Back pain—Epirubicin—hematologic cancer	3.01e-05	0.000146	CcSEcCtD
Misoprostol—Dizziness—Etoposide—hematologic cancer	3e-05	0.000145	CcSEcCtD
Misoprostol—Muscle spasms—Epirubicin—hematologic cancer	2.99e-05	0.000145	CcSEcCtD
Misoprostol—Immune system disorder—Doxorubicin—hematologic cancer	2.99e-05	0.000145	CcSEcCtD
Misoprostol—Chills—Doxorubicin—hematologic cancer	2.97e-05	0.000144	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.96e-05	0.000143	CcSEcCtD
Misoprostol—Dizziness—Prednisolone—hematologic cancer	2.96e-05	0.000143	CcSEcCtD
Misoprostol—Arrhythmia—Doxorubicin—hematologic cancer	2.96e-05	0.000143	CcSEcCtD
Misoprostol—Asthenia—Triamcinolone—hematologic cancer	2.95e-05	0.000143	CcSEcCtD
Misoprostol—Abdominal pain—Dexamethasone—hematologic cancer	2.95e-05	0.000143	CcSEcCtD
Misoprostol—Abdominal pain—Betamethasone—hematologic cancer	2.95e-05	0.000143	CcSEcCtD
Misoprostol—Body temperature increased—Betamethasone—hematologic cancer	2.95e-05	0.000143	CcSEcCtD
Misoprostol—Body temperature increased—Dexamethasone—hematologic cancer	2.95e-05	0.000143	CcSEcCtD
Misoprostol—Nausea—Cisplatin—hematologic cancer	2.94e-05	0.000142	CcSEcCtD
Misoprostol—Alopecia—Doxorubicin—hematologic cancer	2.92e-05	0.000141	CcSEcCtD
Misoprostol—Vomiting—Etoposide—hematologic cancer	2.88e-05	0.000139	CcSEcCtD
Misoprostol—Anaemia—Epirubicin—hematologic cancer	2.88e-05	0.000139	CcSEcCtD
Misoprostol—Dyspepsia—Prednisone—hematologic cancer	2.86e-05	0.000138	CcSEcCtD
Misoprostol—Rash—Etoposide—hematologic cancer	2.86e-05	0.000138	CcSEcCtD
Misoprostol—Dermatitis—Etoposide—hematologic cancer	2.86e-05	0.000138	CcSEcCtD
Misoprostol—Headache—Etoposide—hematologic cancer	2.84e-05	0.000137	CcSEcCtD
Misoprostol—Flatulence—Doxorubicin—hematologic cancer	2.84e-05	0.000137	CcSEcCtD
Misoprostol—Chest pain—Methotrexate—hematologic cancer	2.83e-05	0.000137	CcSEcCtD
Misoprostol—Arthralgia—Methotrexate—hematologic cancer	2.83e-05	0.000137	CcSEcCtD
Misoprostol—Myalgia—Methotrexate—hematologic cancer	2.83e-05	0.000137	CcSEcCtD
Misoprostol—Rash—Prednisolone—hematologic cancer	2.82e-05	0.000136	CcSEcCtD
Misoprostol—Dermatitis—Prednisolone—hematologic cancer	2.82e-05	0.000136	CcSEcCtD
Misoprostol—Fatigue—Prednisone—hematologic cancer	2.8e-05	0.000135	CcSEcCtD
Misoprostol—Headache—Prednisolone—hematologic cancer	2.8e-05	0.000135	CcSEcCtD
Misoprostol—Syncope—Epirubicin—hematologic cancer	2.79e-05	0.000135	CcSEcCtD
Misoprostol—Back pain—Doxorubicin—hematologic cancer	2.79e-05	0.000135	CcSEcCtD
Misoprostol—Constipation—Prednisone—hematologic cancer	2.78e-05	0.000134	CcSEcCtD
Misoprostol—Muscle spasms—Doxorubicin—hematologic cancer	2.77e-05	0.000134	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—FOXO1—hematologic cancer	2.75e-05	0.000234	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—IL2—hematologic cancer	2.75e-05	0.000234	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PDGFRB—hematologic cancer	2.75e-05	0.000233	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—STAT1—hematologic cancer	2.75e-05	0.000233	CbGpPWpGaD
Misoprostol—Confusional state—Methotrexate—hematologic cancer	2.74e-05	0.000132	CcSEcCtD
Misoprostol—Loss of consciousness—Epirubicin—hematologic cancer	2.74e-05	0.000132	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—IL3—hematologic cancer	2.73e-05	0.000231	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—PIK3CB—hematologic cancer	2.72e-05	0.000231	CbGpPWpGaD
Misoprostol—Dizziness—Triamcinolone—hematologic cancer	2.72e-05	0.000131	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—CCL2—hematologic cancer	2.72e-05	0.000231	CbGpPWpGaD
Misoprostol—Anaphylactic shock—Methotrexate—hematologic cancer	2.72e-05	0.000131	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—IL6R—hematologic cancer	2.71e-05	0.00023	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PDGFRA—hematologic cancer	2.71e-05	0.00023	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—JAK1—hematologic cancer	2.7e-05	0.000229	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PRKCG—hematologic cancer	2.7e-05	0.000229	CbGpPWpGaD
Misoprostol—Infection—Methotrexate—hematologic cancer	2.7e-05	0.00013	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—PIK3CG—hematologic cancer	2.69e-05	0.000229	CbGpPWpGaD
Misoprostol—Nausea—Etoposide—hematologic cancer	2.69e-05	0.00013	CcSEcCtD
Misoprostol—Hypertension—Epirubicin—hematologic cancer	2.69e-05	0.00013	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—PTPN1—hematologic cancer	2.68e-05	0.000227	CbGpPWpGaD
Misoprostol—Feeling abnormal—Prednisone—hematologic cancer	2.68e-05	0.000129	CcSEcCtD
Misoprostol—Asthenia—Dexamethasone—hematologic cancer	2.68e-05	0.000129	CcSEcCtD
Misoprostol—Asthenia—Betamethasone—hematologic cancer	2.68e-05	0.000129	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—PIK3R1—hematologic cancer	2.67e-05	0.000226	CbGpPWpGaD
Misoprostol—Anaemia—Doxorubicin—hematologic cancer	2.66e-05	0.000129	CcSEcCtD
Misoprostol—Thrombocytopenia—Methotrexate—hematologic cancer	2.66e-05	0.000129	CcSEcCtD
Misoprostol—Gastrointestinal pain—Prednisone—hematologic cancer	2.66e-05	0.000128	CcSEcCtD
Misoprostol—Nausea—Prednisolone—hematologic cancer	2.66e-05	0.000128	CcSEcCtD
Misoprostol—Myalgia—Epirubicin—hematologic cancer	2.65e-05	0.000128	CcSEcCtD
Misoprostol—Arthralgia—Epirubicin—hematologic cancer	2.65e-05	0.000128	CcSEcCtD
Misoprostol—Chest pain—Epirubicin—hematologic cancer	2.65e-05	0.000128	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—PTPN11—hematologic cancer	2.65e-05	0.000225	CbGpPWpGaD
Misoprostol—Anxiety—Epirubicin—hematologic cancer	2.64e-05	0.000128	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—RASGRP1—hematologic cancer	2.64e-05	0.000224	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—SYK—hematologic cancer	2.63e-05	0.000223	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—HSP90AA1—hematologic cancer	2.63e-05	0.000223	CbGpPWpGaD
Misoprostol—Hyperhidrosis—Methotrexate—hematologic cancer	2.63e-05	0.000127	CcSEcCtD
Misoprostol—Vomiting—Triamcinolone—hematologic cancer	2.61e-05	0.000126	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—PIK3CD—hematologic cancer	2.61e-05	0.000221	CbGpPWpGaD
Misoprostol—Rash—Triamcinolone—hematologic cancer	2.59e-05	0.000125	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—JAK2—hematologic cancer	2.59e-05	0.00022	CbGpPWpGaD
Misoprostol—Dermatitis—Triamcinolone—hematologic cancer	2.59e-05	0.000125	CcSEcCtD
Misoprostol—Syncope—Doxorubicin—hematologic cancer	2.58e-05	0.000125	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—MAP2K1—hematologic cancer	2.58e-05	0.000219	CbGpPWpGaD
Misoprostol—Headache—Triamcinolone—hematologic cancer	2.58e-05	0.000125	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—GRB2—hematologic cancer	2.57e-05	0.000218	CbGpPWpGaD
Misoprostol—Body temperature increased—Prednisone—hematologic cancer	2.57e-05	0.000124	CcSEcCtD
Misoprostol—Abdominal pain—Prednisone—hematologic cancer	2.57e-05	0.000124	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—PIK3CD—hematologic cancer	2.57e-05	0.000218	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—CREB1—hematologic cancer	2.56e-05	0.000218	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PDGFA—hematologic cancer	2.56e-05	0.000217	CbGpPWpGaD
Misoprostol—Confusional state—Epirubicin—hematologic cancer	2.56e-05	0.000124	CcSEcCtD
Misoprostol—Diarrhoea—Dexamethasone—hematologic cancer	2.55e-05	0.000123	CcSEcCtD
Misoprostol—Diarrhoea—Betamethasone—hematologic cancer	2.55e-05	0.000123	CcSEcCtD
Misoprostol—Oedema—Epirubicin—hematologic cancer	2.54e-05	0.000123	CcSEcCtD
Misoprostol—Anaphylactic shock—Epirubicin—hematologic cancer	2.54e-05	0.000123	CcSEcCtD
Misoprostol—Hypotension—Methotrexate—hematologic cancer	2.54e-05	0.000123	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—STAT1—hematologic cancer	2.53e-05	0.000215	CbGpPWpGaD
Misoprostol—Loss of consciousness—Doxorubicin—hematologic cancer	2.53e-05	0.000122	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—KITLG—hematologic cancer	2.53e-05	0.000214	CbGpPWpGaD
Misoprostol—Infection—Epirubicin—hematologic cancer	2.52e-05	0.000122	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—IL2RA—hematologic cancer	2.52e-05	0.000214	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—CCL2—hematologic cancer	2.51e-05	0.000213	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—IL6R—hematologic cancer	2.5e-05	0.000212	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—IL2—hematologic cancer	2.5e-05	0.000212	CbGpPWpGaD
Misoprostol—Shock—Epirubicin—hematologic cancer	2.5e-05	0.000121	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—TERT—hematologic cancer	2.49e-05	0.000211	CbGpPWpGaD
Misoprostol—Thrombocytopenia—Epirubicin—hematologic cancer	2.49e-05	0.00012	CcSEcCtD
Misoprostol—Hypertension—Doxorubicin—hematologic cancer	2.49e-05	0.00012	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.47e-05	0.00012	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—STAT5A—hematologic cancer	2.47e-05	0.00021	CbGpPWpGaD
Misoprostol—Dizziness—Betamethasone—hematologic cancer	2.47e-05	0.000119	CcSEcCtD
Misoprostol—Dizziness—Dexamethasone—hematologic cancer	2.47e-05	0.000119	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—PIK3CB—hematologic cancer	2.46e-05	0.000209	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—PIK3R1—hematologic cancer	2.46e-05	0.000209	CbGpPWpGaD
Misoprostol—Hyperhidrosis—Epirubicin—hematologic cancer	2.46e-05	0.000119	CcSEcCtD
Misoprostol—Myalgia—Doxorubicin—hematologic cancer	2.45e-05	0.000119	CcSEcCtD
Misoprostol—Chest pain—Doxorubicin—hematologic cancer	2.45e-05	0.000119	CcSEcCtD
Misoprostol—Arthralgia—Doxorubicin—hematologic cancer	2.45e-05	0.000119	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—CDKN2B—hematologic cancer	2.45e-05	0.000208	CbGpPWpGaD
Misoprostol—Anxiety—Doxorubicin—hematologic cancer	2.44e-05	0.000118	CcSEcCtD
Misoprostol—Nausea—Triamcinolone—hematologic cancer	2.44e-05	0.000118	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—PDGFB—hematologic cancer	2.43e-05	0.000206	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—PIK3R1—hematologic cancer	2.42e-05	0.000206	CbGpPWpGaD
Misoprostol—Dyspnoea—Methotrexate—hematologic cancer	2.42e-05	0.000117	CcSEcCtD
Misoprostol—Somnolence—Methotrexate—hematologic cancer	2.41e-05	0.000117	CcSEcCtD
Misoprostol—Hypersensitivity—Prednisone—hematologic cancer	2.39e-05	0.000116	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—JAK2—hematologic cancer	2.39e-05	0.000203	CbGpPWpGaD
Misoprostol—Dyspepsia—Methotrexate—hematologic cancer	2.39e-05	0.000116	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—MAP2K1—hematologic cancer	2.38e-05	0.000202	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—TSC2—hematologic cancer	2.38e-05	0.000202	CbGpPWpGaD
Misoprostol—Hypotension—Epirubicin—hematologic cancer	2.37e-05	0.000115	CcSEcCtD
Misoprostol—Vomiting—Dexamethasone—hematologic cancer	2.37e-05	0.000115	CcSEcCtD
Misoprostol—Vomiting—Betamethasone—hematologic cancer	2.37e-05	0.000115	CcSEcCtD
Misoprostol—Confusional state—Doxorubicin—hematologic cancer	2.37e-05	0.000115	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—GRB2—hematologic cancer	2.37e-05	0.000201	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—PIK3CD—hematologic cancer	2.37e-05	0.000201	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CD86—hematologic cancer	2.37e-05	0.000201	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PDGFA—hematologic cancer	2.37e-05	0.000201	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—JAK2—hematologic cancer	2.35e-05	0.0002	CbGpPWpGaD
Misoprostol—Rash—Dexamethasone—hematologic cancer	2.35e-05	0.000114	CcSEcCtD
Misoprostol—Rash—Betamethasone—hematologic cancer	2.35e-05	0.000114	CcSEcCtD
Misoprostol—Oedema—Doxorubicin—hematologic cancer	2.35e-05	0.000114	CcSEcCtD
Misoprostol—Anaphylactic shock—Doxorubicin—hematologic cancer	2.35e-05	0.000114	CcSEcCtD
Misoprostol—Dermatitis—Betamethasone—hematologic cancer	2.35e-05	0.000114	CcSEcCtD
Misoprostol—Dermatitis—Dexamethasone—hematologic cancer	2.35e-05	0.000114	CcSEcCtD
Misoprostol—Fatigue—Methotrexate—hematologic cancer	2.34e-05	0.000113	CcSEcCtD
Misoprostol—Headache—Betamethasone—hematologic cancer	2.34e-05	0.000113	CcSEcCtD
Misoprostol—Headache—Dexamethasone—hematologic cancer	2.34e-05	0.000113	CcSEcCtD
Misoprostol—Infection—Doxorubicin—hematologic cancer	2.34e-05	0.000113	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—HES1—hematologic cancer	2.33e-05	0.000198	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—KITLG—hematologic cancer	2.33e-05	0.000198	CbGpPWpGaD
Misoprostol—Asthenia—Prednisone—hematologic cancer	2.33e-05	0.000113	CcSEcCtD
Misoprostol—Pain—Methotrexate—hematologic cancer	2.32e-05	0.000112	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—NCOR1—hematologic cancer	2.32e-05	0.000197	CbGpPWpGaD
Misoprostol—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.32e-05	0.000112	CcSEcCtD
Misoprostol—Shock—Doxorubicin—hematologic cancer	2.31e-05	0.000112	CcSEcCtD
Misoprostol—Thrombocytopenia—Doxorubicin—hematologic cancer	2.3e-05	0.000111	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—CSF2—hematologic cancer	2.3e-05	0.000195	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—FGF1—hematologic cancer	2.3e-05	0.000195	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—FGFR3—hematologic cancer	2.29e-05	0.000194	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—STAT5A—hematologic cancer	2.28e-05	0.000193	CbGpPWpGaD
Misoprostol—Hyperhidrosis—Doxorubicin—hematologic cancer	2.27e-05	0.00011	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—PIK3CB—hematologic cancer	2.27e-05	0.000193	CbGpPWpGaD
Misoprostol—Dyspnoea—Epirubicin—hematologic cancer	2.27e-05	0.00011	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—MAPK14—hematologic cancer	2.26e-05	0.000192	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—FOXO1—hematologic cancer	2.26e-05	0.000192	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—IL2—hematologic cancer	2.26e-05	0.000192	CbGpPWpGaD
Misoprostol—Somnolence—Epirubicin—hematologic cancer	2.26e-05	0.000109	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—CDKN2B—hematologic cancer	2.26e-05	0.000192	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PDGFRB—hematologic cancer	2.26e-05	0.000192	CbGpPWpGaD
Misoprostol—Feeling abnormal—Methotrexate—hematologic cancer	2.24e-05	0.000108	CcSEcCtD
Misoprostol—Dyspepsia—Epirubicin—hematologic cancer	2.24e-05	0.000108	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—PIK3CB—hematologic cancer	2.24e-05	0.00019	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—PIK3R1—hematologic cancer	2.24e-05	0.00019	CbGpPWpGaD
Misoprostol—Diarrhoea—Prednisone—hematologic cancer	2.22e-05	0.000107	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—PDGFRA—hematologic cancer	2.22e-05	0.000189	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—ESR1—hematologic cancer	2.22e-05	0.000188	CbGpPWpGaD
Misoprostol—Gastrointestinal pain—Methotrexate—hematologic cancer	2.22e-05	0.000107	CcSEcCtD
Misoprostol—Nausea—Dexamethasone—hematologic cancer	2.22e-05	0.000107	CcSEcCtD
Misoprostol—Nausea—Betamethasone—hematologic cancer	2.22e-05	0.000107	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—JAK1—hematologic cancer	2.22e-05	0.000188	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PRKCG—hematologic cancer	2.22e-05	0.000188	CbGpPWpGaD
Misoprostol—Hypotension—Doxorubicin—hematologic cancer	2.2e-05	0.000106	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—FN1—hematologic cancer	2.19e-05	0.000186	CbGpPWpGaD
Misoprostol—Fatigue—Epirubicin—hematologic cancer	2.19e-05	0.000106	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—CD86—hematologic cancer	2.18e-05	0.000185	CbGpPWpGaD
Misoprostol—Pain—Epirubicin—hematologic cancer	2.17e-05	0.000105	CcSEcCtD
Misoprostol—Constipation—Epirubicin—hematologic cancer	2.17e-05	0.000105	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—JAK2—hematologic cancer	2.17e-05	0.000184	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—NFKBIA—hematologic cancer	2.17e-05	0.000184	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—BAD—hematologic cancer	2.17e-05	0.000184	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—HES1—hematologic cancer	2.15e-05	0.000183	CbGpPWpGaD
Misoprostol—Dizziness—Prednisone—hematologic cancer	2.15e-05	0.000104	CcSEcCtD
Misoprostol—Body temperature increased—Methotrexate—hematologic cancer	2.15e-05	0.000104	CcSEcCtD
Misoprostol—Abdominal pain—Methotrexate—hematologic cancer	2.15e-05	0.000104	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—NOTCH1—hematologic cancer	2.15e-05	0.000182	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—NCOR1—hematologic cancer	2.14e-05	0.000182	CbGpPWpGaD
Misoprostol—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.14e-05	0.000104	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—FGF1—hematologic cancer	2.12e-05	0.00018	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CSF2—hematologic cancer	2.12e-05	0.00018	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CD80—hematologic cancer	2.1e-05	0.000178	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PIK3CG—hematologic cancer	2.1e-05	0.000178	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—KIT—hematologic cancer	2.1e-05	0.000178	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—NRAS—hematologic cancer	2.1e-05	0.000178	CbGpPWpGaD
Misoprostol—Dyspnoea—Doxorubicin—hematologic cancer	2.1e-05	0.000101	CcSEcCtD
Misoprostol—Feeling abnormal—Epirubicin—hematologic cancer	2.09e-05	0.000101	CcSEcCtD
Misoprostol—Somnolence—Doxorubicin—hematologic cancer	2.09e-05	0.000101	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—FOXO1—hematologic cancer	2.09e-05	0.000177	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—IL2—hematologic cancer	2.09e-05	0.000177	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PDGFRB—hematologic cancer	2.08e-05	0.000177	CbGpPWpGaD
Misoprostol—Gastrointestinal pain—Epirubicin—hematologic cancer	2.08e-05	0.0001	CcSEcCtD
Misoprostol—Dyspepsia—Doxorubicin—hematologic cancer	2.07e-05	0.0001	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—IL2RA—hematologic cancer	2.07e-05	0.000176	CbGpPWpGaD
Misoprostol—Vomiting—Prednisone—hematologic cancer	2.07e-05	9.99e-05	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—PIK3CB—hematologic cancer	2.06e-05	0.000175	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PTPN11—hematologic cancer	2.06e-05	0.000175	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—IL2—hematologic cancer	2.05e-05	0.000174	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PDGFRA—hematologic cancer	2.05e-05	0.000174	CbGpPWpGaD
Misoprostol—Rash—Prednisone—hematologic cancer	2.05e-05	9.91e-05	CcSEcCtD
Misoprostol—Dermatitis—Prednisone—hematologic cancer	2.05e-05	9.9e-05	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—TERT—hematologic cancer	2.05e-05	0.000174	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—JAK1—hematologic cancer	2.04e-05	0.000174	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PRKCG—hematologic cancer	2.04e-05	0.000174	CbGpPWpGaD
Misoprostol—Headache—Prednisone—hematologic cancer	2.04e-05	9.84e-05	CcSEcCtD
Misoprostol—Fatigue—Doxorubicin—hematologic cancer	2.03e-05	9.8e-05	CcSEcCtD
Misoprostol—Pain—Doxorubicin—hematologic cancer	2.01e-05	9.72e-05	CcSEcCtD
Misoprostol—Constipation—Doxorubicin—hematologic cancer	2.01e-05	9.72e-05	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—MAPK3—hematologic cancer	2.01e-05	0.000171	CbGpPWpGaD
Misoprostol—Body temperature increased—Epirubicin—hematologic cancer	2.01e-05	9.71e-05	CcSEcCtD
Misoprostol—Abdominal pain—Epirubicin—hematologic cancer	2.01e-05	9.71e-05	CcSEcCtD
Misoprostol—Hypersensitivity—Methotrexate—hematologic cancer	2e-05	9.67e-05	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—CREB1—hematologic cancer	2e-05	0.00017	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PDGFB—hematologic cancer	2e-05	0.000169	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—BRAF—hematologic cancer	1.97e-05	0.000167	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CCL2—hematologic cancer	1.96e-05	0.000166	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—TSC2—hematologic cancer	1.95e-05	0.000166	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IL6R—hematologic cancer	1.95e-05	0.000165	CbGpPWpGaD
Misoprostol—Asthenia—Methotrexate—hematologic cancer	1.95e-05	9.42e-05	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—CREBBP—hematologic cancer	1.95e-05	0.000165	CbGpPWpGaD
Misoprostol—Feeling abnormal—Doxorubicin—hematologic cancer	1.94e-05	9.37e-05	CcSEcCtD
Misoprostol—Nausea—Prednisone—hematologic cancer	1.93e-05	9.33e-05	CcSEcCtD
Misoprostol—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.92e-05	9.3e-05	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—IL2RA—hematologic cancer	1.91e-05	0.000162	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—IL2—hematologic cancer	1.9e-05	0.000161	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TERT—hematologic cancer	1.89e-05	0.00016	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—FGFR3—hematologic cancer	1.88e-05	0.000159	CbGpPWpGaD
Misoprostol—Hypersensitivity—Epirubicin—hematologic cancer	1.87e-05	9.05e-05	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—MAPK14—hematologic cancer	1.86e-05	0.000158	CbGpPWpGaD
Misoprostol—Body temperature increased—Doxorubicin—hematologic cancer	1.86e-05	8.99e-05	CcSEcCtD
Misoprostol—Abdominal pain—Doxorubicin—hematologic cancer	1.86e-05	8.99e-05	CcSEcCtD
Misoprostol—Diarrhoea—Methotrexate—hematologic cancer	1.86e-05	8.98e-05	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—MAP2K1—hematologic cancer	1.86e-05	0.000158	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PIK3CD—hematologic cancer	1.85e-05	0.000157	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PDGFB—hematologic cancer	1.84e-05	0.000156	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—PIK3CA—hematologic cancer	1.83e-05	0.000155	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—ESR1—hematologic cancer	1.82e-05	0.000155	CbGpPWpGaD
Misoprostol—Asthenia—Epirubicin—hematologic cancer	1.82e-05	8.82e-05	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—KRAS—hematologic cancer	1.81e-05	0.000153	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TSC2—hematologic cancer	1.8e-05	0.000153	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—FN1—hematologic cancer	1.8e-05	0.000153	CbGpPWpGaD
Misoprostol—Dizziness—Methotrexate—hematologic cancer	1.8e-05	8.68e-05	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—BAD—hematologic cancer	1.78e-05	0.000151	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—NFKBIA—hematologic cancer	1.78e-05	0.000151	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—FGF2—hematologic cancer	1.77e-05	0.00015	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—NOTCH1—hematologic cancer	1.76e-05	0.00015	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PIK3R1—hematologic cancer	1.74e-05	0.000148	CbGpPWpGaD
Misoprostol—Diarrhoea—Epirubicin—hematologic cancer	1.74e-05	8.41e-05	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—FGFR3—hematologic cancer	1.73e-05	0.000147	CbGpPWpGaD
Misoprostol—Hypersensitivity—Doxorubicin—hematologic cancer	1.73e-05	8.38e-05	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—CD80—hematologic cancer	1.73e-05	0.000147	CbGpPWpGaD
Misoprostol—Vomiting—Methotrexate—hematologic cancer	1.73e-05	8.35e-05	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—KIT—hematologic cancer	1.72e-05	0.000146	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PIK3CG—hematologic cancer	1.72e-05	0.000146	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—NRAS—hematologic cancer	1.72e-05	0.000146	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MAPK14—hematologic cancer	1.72e-05	0.000146	CbGpPWpGaD
Misoprostol—Rash—Methotrexate—hematologic cancer	1.71e-05	8.28e-05	CcSEcCtD
Misoprostol—Dermatitis—Methotrexate—hematologic cancer	1.71e-05	8.27e-05	CcSEcCtD
Misoprostol—Headache—Methotrexate—hematologic cancer	1.7e-05	8.22e-05	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—JAK2—hematologic cancer	1.69e-05	0.000144	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PTPN11—hematologic cancer	1.69e-05	0.000144	CbGpPWpGaD
Misoprostol—Asthenia—Doxorubicin—hematologic cancer	1.69e-05	8.16e-05	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—ESR1—hematologic cancer	1.68e-05	0.000143	CbGpPWpGaD
Misoprostol—Dizziness—Epirubicin—hematologic cancer	1.68e-05	8.12e-05	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—FN1—hematologic cancer	1.66e-05	0.000141	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—PIK3CA—hematologic cancer	1.66e-05	0.000141	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MDM2—hematologic cancer	1.65e-05	0.00014	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—MAPK3—hematologic cancer	1.65e-05	0.00014	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—BAD—hematologic cancer	1.64e-05	0.000139	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—NFKBIA—hematologic cancer	1.64e-05	0.000139	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CREB1—hematologic cancer	1.64e-05	0.000139	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—NOTCH1—hematologic cancer	1.63e-05	0.000138	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—BRAF—hematologic cancer	1.62e-05	0.000138	CbGpPWpGaD
Misoprostol—Vomiting—Epirubicin—hematologic cancer	1.62e-05	7.81e-05	CcSEcCtD
Misoprostol—Nausea—Methotrexate—hematologic cancer	1.61e-05	7.8e-05	CcSEcCtD
Misoprostol—Diarrhoea—Doxorubicin—hematologic cancer	1.61e-05	7.78e-05	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—PIK3CB—hematologic cancer	1.61e-05	0.000136	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MTOR—hematologic cancer	1.61e-05	0.000136	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CCL2—hematologic cancer	1.61e-05	0.000136	CbGpPWpGaD
Misoprostol—Rash—Epirubicin—hematologic cancer	1.6e-05	7.75e-05	CcSEcCtD
Misoprostol—Dermatitis—Epirubicin—hematologic cancer	1.6e-05	7.74e-05	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—IL6R—hematologic cancer	1.6e-05	0.000136	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CREBBP—hematologic cancer	1.6e-05	0.000136	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CD80—hematologic cancer	1.59e-05	0.000135	CbGpPWpGaD
Misoprostol—Headache—Epirubicin—hematologic cancer	1.59e-05	7.7e-05	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—PIK3CG—hematologic cancer	1.59e-05	0.000135	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—KIT—hematologic cancer	1.59e-05	0.000135	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—NRAS—hematologic cancer	1.59e-05	0.000135	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PTPN11—hematologic cancer	1.56e-05	0.000133	CbGpPWpGaD
Misoprostol—Dizziness—Doxorubicin—hematologic cancer	1.55e-05	7.52e-05	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—HRAS—hematologic cancer	1.54e-05	0.00013	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MAP2K1—hematologic cancer	1.53e-05	0.000129	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—MAPK3—hematologic cancer	1.52e-05	0.000129	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PIK3CD—hematologic cancer	1.52e-05	0.000129	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CREB1—hematologic cancer	1.51e-05	0.000129	CbGpPWpGaD
Misoprostol—Nausea—Epirubicin—hematologic cancer	1.51e-05	7.3e-05	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—CDKN1B—hematologic cancer	1.51e-05	0.000128	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—PIK3CA—hematologic cancer	1.5e-05	0.000127	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—BRAF—hematologic cancer	1.5e-05	0.000127	CbGpPWpGaD
Misoprostol—Vomiting—Doxorubicin—hematologic cancer	1.5e-05	7.23e-05	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—AKT1—hematologic cancer	1.49e-05	0.000127	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—KRAS—hematologic cancer	1.48e-05	0.000126	CbGpPWpGaD
Misoprostol—Rash—Doxorubicin—hematologic cancer	1.48e-05	7.17e-05	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—CCL2—hematologic cancer	1.48e-05	0.000126	CbGpPWpGaD
Misoprostol—Dermatitis—Doxorubicin—hematologic cancer	1.48e-05	7.16e-05	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—CASP3—hematologic cancer	1.48e-05	0.000126	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IL6R—hematologic cancer	1.48e-05	0.000125	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IL2—hematologic cancer	1.48e-05	0.000125	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CREBBP—hematologic cancer	1.47e-05	0.000125	CbGpPWpGaD
Misoprostol—Headache—Doxorubicin—hematologic cancer	1.47e-05	7.12e-05	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—IL6—hematologic cancer	1.47e-05	0.000125	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—FGF2—hematologic cancer	1.45e-05	0.000123	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CCND1—hematologic cancer	1.44e-05	0.000122	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—JUN—hematologic cancer	1.44e-05	0.000122	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PIK3R1—hematologic cancer	1.43e-05	0.000121	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MAP2K1—hematologic cancer	1.41e-05	0.000119	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PIK3CD—hematologic cancer	1.4e-05	0.000119	CbGpPWpGaD
Misoprostol—Nausea—Doxorubicin—hematologic cancer	1.4e-05	6.75e-05	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—CDKN1A—hematologic cancer	1.39e-05	0.000118	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—JAK2—hematologic cancer	1.39e-05	0.000118	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PTEN—hematologic cancer	1.39e-05	0.000118	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—PIK3CA—hematologic cancer	1.39e-05	0.000118	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—KRAS—hematologic cancer	1.37e-05	0.000116	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—PIK3CA—hematologic cancer	1.36e-05	0.000116	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MAPK8—hematologic cancer	1.36e-05	0.000115	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MDM2—hematologic cancer	1.36e-05	0.000115	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—AKT1—hematologic cancer	1.36e-05	0.000115	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—FGF2—hematologic cancer	1.34e-05	0.000114	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—EP300—hematologic cancer	1.33e-05	0.000112	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MTOR—hematologic cancer	1.32e-05	0.000112	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PIK3CB—hematologic cancer	1.32e-05	0.000112	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PIK3R1—hematologic cancer	1.32e-05	0.000112	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—SRC—hematologic cancer	1.29e-05	0.000109	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—JAK2—hematologic cancer	1.28e-05	0.000109	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—HRAS—hematologic cancer	1.26e-05	0.000107	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—PIK3CA—hematologic cancer	1.26e-05	0.000107	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—VEGFA—hematologic cancer	1.26e-05	0.000107	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MDM2—hematologic cancer	1.25e-05	0.000106	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—STAT3—hematologic cancer	1.24e-05	0.000105	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—NRAS—hematologic cancer	1.24e-05	0.000105	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CDKN1B—hematologic cancer	1.24e-05	0.000105	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—AKT1—hematologic cancer	1.23e-05	0.000104	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MTOR—hematologic cancer	1.22e-05	0.000103	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PIK3CB—hematologic cancer	1.22e-05	0.000103	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CASP3—hematologic cancer	1.21e-05	0.000103	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IL2—hematologic cancer	1.21e-05	0.000103	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—IL6—hematologic cancer	1.21e-05	0.000102	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MAPK3—hematologic cancer	1.19e-05	0.000101	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CCND1—hematologic cancer	1.18e-05	0.0001	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—JUN—hematologic cancer	1.18e-05	0.0001	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—HRAS—hematologic cancer	1.16e-05	9.88e-05	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MYC—hematologic cancer	1.16e-05	9.8e-05	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—TGFB1—hematologic cancer	1.15e-05	9.78e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CDKN1A—hematologic cancer	1.14e-05	9.71e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CDKN1B—hematologic cancer	1.14e-05	9.71e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PTEN—hematologic cancer	1.14e-05	9.69e-05	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—AKT1—hematologic cancer	1.13e-05	9.6e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CASP3—hematologic cancer	1.12e-05	9.51e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IL2—hematologic cancer	1.12e-05	9.5e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MAPK8—hematologic cancer	1.12e-05	9.48e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—IL6—hematologic cancer	1.11e-05	9.45e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—AKT1—hematologic cancer	1.11e-05	9.45e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CCND1—hematologic cancer	1.09e-05	9.26e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—JUN—hematologic cancer	1.09e-05	9.24e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—EP300—hematologic cancer	1.09e-05	9.24e-05	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—KRAS—hematologic cancer	1.07e-05	9.06e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—SRC—hematologic cancer	1.06e-05	8.98e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CDKN1A—hematologic cancer	1.06e-05	8.96e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PTEN—hematologic cancer	1.05e-05	8.94e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—VEGFA—hematologic cancer	1.03e-05	8.75e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MAPK8—hematologic cancer	1.03e-05	8.74e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—AKT1—hematologic cancer	1.03e-05	8.72e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—STAT3—hematologic cancer	1.02e-05	8.66e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—NRAS—hematologic cancer	1.02e-05	8.64e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—EP300—hematologic cancer	1e-05	8.52e-05	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PIK3CA—hematologic cancer	9.81e-06	8.32e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—SRC—hematologic cancer	9.77e-06	8.29e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MAPK3—hematologic cancer	9.75e-06	8.28e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—VEGFA—hematologic cancer	9.51e-06	8.07e-05	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—TP53—hematologic cancer	9.49e-06	8.05e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MYC—hematologic cancer	9.49e-06	8.05e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—TGFB1—hematologic cancer	9.46e-06	8.03e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—STAT3—hematologic cancer	9.42e-06	7.99e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—NRAS—hematologic cancer	9.4e-06	7.98e-05	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—HRAS—hematologic cancer	9.07e-06	7.7e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MAPK3—hematologic cancer	9e-06	7.64e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—KRAS—hematologic cancer	8.76e-06	7.44e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MYC—hematologic cancer	8.75e-06	7.43e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TGFB1—hematologic cancer	8.73e-06	7.41e-05	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IL6—hematologic cancer	8.68e-06	7.37e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—KRAS—hematologic cancer	8.09e-06	6.86e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PIK3CA—hematologic cancer	8.05e-06	6.83e-05	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—AKT1—hematologic cancer	8.01e-06	6.8e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—TP53—hematologic cancer	7.79e-06	6.61e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—HRAS—hematologic cancer	7.45e-06	6.32e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PIK3CA—hematologic cancer	7.43e-06	6.31e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TP53—hematologic cancer	7.19e-06	6.1e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IL6—hematologic cancer	7.13e-06	6.05e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—HRAS—hematologic cancer	6.87e-06	5.83e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IL6—hematologic cancer	6.58e-06	5.58e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—AKT1—hematologic cancer	6.58e-06	5.58e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—AKT1—hematologic cancer	6.07e-06	5.15e-05	CbGpPWpGaD
